What is Arcus Biosciences, Inc. (RCUS)?
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer immunotherapies. The company specializes in the discovery and development of small molecule drugs that modulate the immune system to enhance the body's ability to fight cancer. Arcus Biosciences' research pipeline includes therapies targeting immune checkpoint pathways and other mechanisms involved in tumor immune evasion. The company collaborates with academic institutions and other biopharmaceutical firms to advance its drug candidates through clinical trials. Its approach centers on combining immuno-oncology agents to improve therapeutic efficacy and patient outcomes. Arcus Biosciences operates within the broader field of oncology drug development, contributing to the advancement of novel treatments for various types of cancer.
Arcus Biosciences, Inc. Stock Price Today: Live Overview
The price today is shaped by current market trends in trading, with Arcus Biosciences, Inc. standing at $22.27. The price has fluctuated between $21.77 and $22.34 during the session, marking a daily percentage change of -1.2511%.
FAQ: Arcus Biosciences, Inc. (RCUS)
What is the current price of RCUS stock?
The latest price recorded is $22.27.
Does RCUS pay dividends?
Arcus Biosciences, Inc. does not pay dividends.
Does RCUS have a formal corporate presence or regional headquarters in the UAE?
Arcus Biosciences operates in the UAE only via partners and distributors without an official regional office.
What is RCUS best known for?
The company is most famous for developing cancer immunotherapy treatments.
What assets are typically shown together with RCUS?
Commonly shown alongside RCUS: Merck & Co Inc, SNDL Inc., Medical Developments International
Latest shares articles



